BOEING (BA)
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for BA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BA | Chairman & CEO, Amgen | 63 | ["Chairman and CEO, Amgen Inc. (Chairman 2013-present; CEO 2012-present)","President and COO, Amgen Inc. (2010-2012)","Executive Vice President and CFO, Amgen Inc. (2007-2010)","Engineering/Technology Leadership","Complex Manufacturing Expertise","Safety","Risk Management","Highly Regulated Industry Experience","Human Capital Management","International Leadership and Global Relationships","Environmental Risks/Sustainability","Fortune 500 Board Experience","CEO of a Large Company","Fortune 500 CFO","Senior Leadership Experience"] | ["Comp.","GPP","Governance & Public Policy","Compensation"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| AMGN | Chairman of the Board; Chief Executive Officer and President | 63 | ["President since 2010","Chief Executive Officer since 2012","Former Chief Operating Officer from 2010 to 2012","Former Vice President, Operations Strategy at Amgen","Former Managing Director at Morgan Stanley in London","Director of The Boeing Company since 2016","Board of trustees of USC since 2014","Bachelor’s degree in biology from Amherst College","Master’s degree in business administration from Harvard Business School"] | ["Compensation and Management Development","C","M","Equity Award","Executive"] | 2026 |
| NSC | Chairman and CEO; Chairman of the Board | 54 | ["Chairman and CEO Amgen, Inc.", "CEO/Senior Officer", "Environmental and Safety", "Finance and Accounting", "Governance/Board", "Governmental Relations", "Information Technology", "Strategic Planning"] | ["Audit", "Governance and Nominating"] | 2017 |
Biography sourced from the proxy statement filing.
Chairman and CEO, Amgen Inc. Robert A. Bradway Boeing director since: 2016. Committees: Governance & Public Policy (Chair), Compensation. Independent: Yes. Age: 63. Other current public directorships: Amgen Inc. Professional highlights: Chairman and CEO, Amgen Inc. (Chairman 2013-present; CEO 2012-present); President and COO, Amgen Inc. (2010-2012); Executive Vice President and CFO, Amgen Inc. (2007-2010). Mr. Bradway brings to the Board critical skills in the areas of high technology, product development, financial oversight, product safety and risk management. His experience as a senior executive in the biotechnology industry, including as Chief Executive Officer, Chief Operating Officer and Chief Financial Officer of Amgen, provides him with an extensive understanding of the strategic considerations and challenges associated with meeting the requirements of numerous safety and regulatory compliance regimes around the world. At Amgen, Mr. Bradway has also overseen a number of sustainability initiatives. In addition, he previously served as a director of Norfolk Southern Corporation, one of the nation s largest railroad transportation companies, where virtually every aspect of operations is heavily regulated and subject to strict safety-related oversight. Key skills and qualifications: Engineering/Technology Leadership, Complex Manufacturing Expertise, Safety, Risk Management, Highly Regulated Industry Experience, Human Capital Management, International Leadership and Global Relationships, Environmental Risks/Sustainability, Fortune 500 Board Experience, CEO of a Large Company, Fortune 500 CFO, Senior Leadership Experience.